Bergeron M G
Scand J Infect Dis Suppl. 1978(14):189-206.
The advent of several new antibiotics able to counter drug-resistant bacteria, the problems in carrying out well-controlled clinical trials and the occasional disparity between in vitro and in vivo activity of antimicrobials compel us to resort to experiments using animal models in order to evaluate different therapeutic regimens. We wish here to discuss the prerequisites of a reliable animal model for the therapy of experimental infections and to analyze the influence of combined antimicrobial therapy on the outcome of non-human infections. The interaction between antibiotics and infected tissues will also be considered. Finally, we shall examine the interrelations between host defenses and antibiotics in models for experimental infections.
几种能够对抗耐药菌的新型抗生素的出现、开展严格对照临床试验存在的问题以及抗菌药物体外活性与体内活性之间偶尔出现的差异,迫使我们借助动物模型实验来评估不同的治疗方案。在此,我们希望讨论用于治疗实验性感染的可靠动物模型的先决条件,并分析联合抗菌治疗对非人感染结局的影响。还将考虑抗生素与感染组织之间的相互作用。最后,我们将研究实验性感染模型中宿主防御与抗生素之间的相互关系。